Chad Waite
Managing Director @ OVP Venture Partners
Chad Waite is a funding round investor at OVP Venture Partners focused on Software and Biotechnology. Chad Waite joined OVP Venture Partners in 1987 and focuses on investments in the digital biology, and network security sectors. His investments include 4thPass, Accelerator, Adapx, Airgo Networks, Boston Beer, Cardima, CellPro, Complete Genomics, Corixa, Filenet, GenoLogics, Limerick BioPharma, Loudeye Technologies, NanoString, Napera Networks,ProTools, Quantum Medical, Raytel Medical, Returns Online, Rosetta Inpharmatics, SafeHarbor, Saros, Seattle Genetics, SignalSoft, Syntellect, Vantos, Verdezyne, Verity, and WatchGuard. He currently serves on the Board of Directors of Accelerator, Adapx, Aggregate Knowledge, NanoString, Symform, Verdezyne and The W Fund, and is a Board Observer to Talyst.Prior to joining OVP, Chad was a General Partner at Hambrecht & Quist Venture Partners where he focused on investments in IT and life sciences. Prior to H&Q, he was in marketing and sales management at Cobe Laboratories, Inc. in its cardiovascular medical products division.Chad received his BA in History from Kenyon College and his MBA from Harvard Business School. He is a Trustee at Kenyon College and has also served as a board member of the NVCA. He is the proud father of three grown children, is an avid cyclist and snowboarder, and loves fine wine.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Chad Waite invests in
Stages Chad Waite invests in
Countries Chad Waite invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 2 (12%)
- Biotechnology 2 (12%)
- CRM 1 (6%)
- Apps 1 (6%)
- Banking 1 (6%)
Stage
- Funding Round 5 (29%)
- Series A 3 (18%)
- Series B 2 (12%)
- Series C 1 (6%)
- Series D 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Verdezyne was a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercialfermentation processes for the production of petrochemical replacements. | $48M / Mar 28, 2014 | ||
| Adapx offers software that turns natural speech, sketches, and handwriting into data for Microsoft Office and other back-end systems. By simply speaking and writing, teams get instant access to structured data collected on paper, touchscreens, mobile devices, and wall displays. A range of enterprises and agencies speed workflows and reduce risk byusing Capturx to bypass data transcription from paper and cumbersome keyboard- and menu-driven interfaces.Adapx was formerly known as Natural Interaction Systems. The company was founded in 1999 and is based in Seattle, Washington. | $3M / Apr 11, 2013 | ||
| NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.NanoString's products are based on a novel digital molecularbarcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer. | $15.3M / Series E / Dec 03, 2012 | ||
| Adapx offers software that turns natural speech, sketches, and handwriting into data for Microsoft Office and other back-end systems. By simply speaking and writing, teams get instant access to structured data collected on paper, touchscreens, mobile devices, and wall displays. A range of enterprises and agencies speed workflows and reduce risk byusing Capturx to bypass data transcription from paper and cumbersome keyboard- and menu-driven interfaces.Adapx was formerly known as Natural Interaction Systems. The company was founded in 1999 and is based in Seattle, Washington. | $3M / Jul 30, 2012 | ||
| Symform develops cost effective solutions to large scale distributed data management problems. The Symform Cooperative Storage Cloud is a solution that combines the best practices of disaster recovery, data security and distributed networking using the power of Internet.The big idea is simple: Give local storage, get online storage. Memberscontribute unused server space equal to the amount they consume in the storage cloud. Symform handles the day-to-day management of network security and administration of the storage cloud. | $11M / Series B / Apr 25, 2012 | ||
| Symform develops cost effective solutions to large scale distributed data management problems. The Symform Cooperative Storage Cloud is a solution that combines the best practices of disaster recovery, data security and distributed networking using the power of Internet.The big idea is simple: Give local storage, get online storage. Memberscontribute unused server space equal to the amount they consume in the storage cloud. Symform handles the day-to-day management of network security and administration of the storage cloud. | $2M / Jan 24, 2012 | ||
| NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.NanoString's products are based on a novel digital molecularbarcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer. | $20M / Series D / Nov 07, 2011 | ||
| Adapx offers software that turns natural speech, sketches, and handwriting into data for Microsoft Office and other back-end systems. By simply speaking and writing, teams get instant access to structured data collected on paper, touchscreens, mobile devices, and wall displays. A range of enterprises and agencies speed workflows and reduce risk byusing Capturx to bypass data transcription from paper and cumbersome keyboard- and menu-driven interfaces.Adapx was formerly known as Natural Interaction Systems. The company was founded in 1999 and is based in Seattle, Washington. | $5M / May 20, 2011 | ||
| Symform develops cost effective solutions to large scale distributed data management problems. The Symform Cooperative Storage Cloud is a solution that combines the best practices of disaster recovery, data security and distributed networking using the power of Internet.The big idea is simple: Give local storage, get online storage. Memberscontribute unused server space equal to the amount they consume in the storage cloud. Symform handles the day-to-day management of network security and administration of the storage cloud. | $4M / Jul 01, 2010 | ||
| Symform develops cost effective solutions to large scale distributed data management problems. The Symform Cooperative Storage Cloud is a solution that combines the best practices of disaster recovery, data security and distributed networking using the power of Internet.The big idea is simple: Give local storage, get online storage. Memberscontribute unused server space equal to the amount they consume in the storage cloud. Symform handles the day-to-day management of network security and administration of the storage cloud. | $1.5M / Series A / Apr 27, 2009 | ||
| See all 17 investments → | |||
Co-Investors
About OVP Venture Partners
OVP Venture Partners is a venture capital firm specializing in early-stage technology-based companies.
OVP Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Gordon Steele
Board Member
|
|||
Bill Funcannon
Controller, Managing Director & CFO
|
|||
|
Chad Waite
Managing Director
|
|||
|
Dick Strayer
Founder & CEO
|
|||
Gerry Langeler
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Chad Waite invest in?
Chad Waite invests primarily in Software, Biotechnology and CRM startups, most often at Funding Round and Series A stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Chad Waite?
Public channels for Chad Waite include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Chad Waite last invest?
The most recent investment recorded for Chad Waite closed in Mar 2014. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
